AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metaross G 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Maxamus Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metaross G 1mg/500mg Tablet

Glimepiride/Metformin 1mg/500mg tablets are classified as antidiabetic medications, combining two drugs for adult type 2 diabetes management. This combination helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication even if you feel well or your blood sugar is controlled; abrupt cessation can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize hypoglycemia symptoms—sweating, dizziness, headache, trembling—and know how to manage them. Consistent meals and readily available glucose sources (e.g., sugary foods, fruit juice) are crucial. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before starting this medication. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) may be recommended by your doctor.

Primary Ingredients of Metaross G 1mg/500mg Tablet

No text provided to rephrase.

Uses of Metaross G 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Metaross G 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Metaross G 1mg/500mg tablet whole; avoid chewing, crushing, or breaking it. It should be taken with a meal.

Common Side effects of Metaross G 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metaross G 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Metaross G 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Metaross G 1mg/500mg Tablet works:

Glimepiride/Metformin 1mg/500mg tablets (Metaross G) combine two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Metaross G 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metaross G 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Metaross G 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metaross G 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Metaross G 1mg/500mg tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Metaross G 1mg/500mg tablets cautiously. Dosage modification may be necessary for these patients. Physician consultation is advised. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; the medication is contraindicated in cases of severe liver dysfunction.

What if you forget to take Metaross G 1mg/500mg Tablet :

Should you forget to take your Metaross G 1mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Metaross G 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Metaross G 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Metaross G 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this risk is heightened in patients with kidney disease, the elderly, and those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metaross G 1mg/500mg Tablets and seek immediate medical attention.
Metaross G 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 DM.
Metaross G 1mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Metaross G 1mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended annually, according to some researchers.
Metaross G 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metaross G 1mg/500mg Tablet with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Metaross G 1mg/500mg Tabl...
37
MRP 45
17% off